Development of fed-batch profiles for efficient biosynthesis of catechol-O-methyltransferase

Area of Science:

• Biotechnology
• Enzyme Production
• Metabolic Engineering

Background:

• Catechol-O-methyltransferase (COMT) is vital in dopamine metabolism and linked to neurodegenerative diseases like Parkinson's.
• Effective COMT inhibitors are sought for Parkinson's disease therapies, requiring large quantities of active COMT.
• Biotechnological up-scaling of COMT production is essential for developing new therapeutic strategies.

Purpose of the Study:

• To develop an optimized fed-batch fermentation process for high-yield production of soluble human COMT (hSCOMT) in Escherichia coli.
• To evaluate and control key process parameters influencing enzyme production and cell viability.
• To establish a scalable and efficient method for recombinant COMT biosynthesis.

Main Methods:

• Optimization of dissolved oxygen, carbon/nitrogen sources, and feeding profiles in a fed-batch culture of E. coli.
• Systematic control of fermentation parameters including pH, temperature, feeding, and induction timing.
• Evaluation of batch and fed-batch strategies for hSCOMT production.

Main Results:

• Achieved a specific COMT activity of 442.34 nmol/h/mg.
• Maintained approximately 80% cell viability at the end of fermentation.
• Demonstrated significant improvement in hSCOMT production yields compared to previous methods.

Conclusions:

• The developed fed-batch process offers a viable and improved method for large-scale hSCOMT production.
• Constant feeding profiles in fed-batch fermentation are effective for enhancing recombinant enzyme yield.
• This work provides a scalable biotechnological solution for producing active COMT for therapeutic research.